Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
Profusa Inc.

PFSA

$0.60Jul 11, 2025 – Apr 30, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$1M
MVM
-$0.3M
BLE
-0.015
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$187.50
2025
Since 2025
-99.7%
vs SPY +14.6%
All-time High
$412.50 · Jul 2025
-99.9% from peak
MVM Rank
#115 of 192
Health Care Equipment
Reaction Win Rate
35%
21 of 60 events

Profusa Inc. has returned -99.7% from $187.50 since 2025, trailing SPY's +14.6% over the same period. The stock hit an all-time high of $412.50 in Jul 2025 and is currently 99.9% below that level. Of 60 tracked news events, 35% produced a positive market-adjusted return.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-04-02+219.0%newsStock TitanNVACW SEC Filings - Profusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
2026-04-03+143.6%newsUBND thành phố Hải PhòngPFSA Stock Analysis: Profusa Inc gains 31 percent to 0.76 on strong intraday momentum - UBND thành phố Hải Phòng
2026-04-06+64.4%newsAssociated PressBC-Most Active Stocks
2026-04-06+64.4%newsGlobeNewswireProfusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
2026-04-06+64.4%newsStocktwitsWhy Did PFSA Stock Surge 150% Today? - Stocktwits
2026-04-06+64.4%newsStock TitanProfusa (Nasdaq: PFSA) signs $30M PanOmics diagnostics LOI - Stock Titan
2026-04-06+64.4%M&ACoinCentralProfusa (PFSA) Stock Rockets 173% After $30M Oncology Platform Deal - CoinCentral
2026-04-06+64.4%newstimothysykes.comProfusa’s Strategic Meeting Sparks Investment Talks - timothysykes.com
2026-04-06+64.4%newsBenzinga12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
2026-04-06+64.4%M&Aparameter.ioProfusa (PFSA) Stock Soars 173% on $30M PanOmics Acquisition Agreement - parameter.io
2025-12-30+55.3%newsSeeking AlphaProfusa restructures senior secured convertible notes
2025-12-30+55.3%newsSahmProfusa Stock Soars—To 12 Cents—On Debt Restructuring - Sahm
2025-12-30+55.3%newsBenzingaNio, Profusa, Nike, FTAI Aviation And Under Armour: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
2025-09-11+47.9%newsChartMillPFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
2025-09-11+47.9%newsStock TitanAI-Powered Continuous Biomarker Monitoring: Profusa Teams with NVIDIA for Revolutionary Health Portal - Stock Titan
2025-09-11+47.9%newsChartMillPFSA Stock Price, Quote & Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
2025-07-14-42.6%newsTradingViewPFSA Stock Price and Chart — NASDAQ:PFSA - TradingView
2025-07-14-42.6%newsTradingViewTechnical Analysis of Profusa, Inc. (NASDAQ:PFSA) - TradingView
2025-07-15-38.0%newsCoinCodexProfusa, Inc. Common Stock (PFSA) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2026-02-13-38.0%newsGlobeNewswireProfusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
2026-02-05-33.2%newsGlobeNewswireProfusa Announces 1-for-75 Reverse Stock Split
2026-02-05-33.2%newsGlobeNewswireProfusa Announces 1-for-75 Reverse Stock Split - GlobeNewswire
2026-02-05-33.2%newsStock TitanProfusa to shrink share count from 92.4M to 1.2M in reverse split - Stock Titan
2026-04-10-31.9%newsCổng thông tin điện tử Tỉnh Sơn LaIs Profusa (PFSA) Stock Good for Beginners | Price at $0.86, Down 17.62% - Large Cap Trends - Cổng thông tin điện tử Tỉnh Sơn La
2025-10-31-26.9%newsStock TitanPFSA flagged by Nasdaq for MVPHS shortfall; delisting risk if not cured - Stock Titan
2025-12-15-26.4%legalStock TitanProfusa (Nasdaq: PFSA) U.S. Lumee PAD study hits endpoints, backs potential FDA filing - Stock Titan
2025-07-16-23.3%newsTradingViewFree float of Profusa, Inc. – NASDAQ:PFSA - TradingView
2025-07-16-23.3%analystZacks Investment ResearchWhat is the current Price Target and Forecast for PROFUSA, Inc. (PFSA) - Zacks Investment Research
2025-07-16-23.3%newsZacks Investment ResearchShould I buy PROFUSA, Inc. (PFSA) - Zacks Investment Research
2025-11-19-23.3%earningsStock TitanProfusa (Nasdaq: PFSA) Targets 2026 Lumee Oxygen Revenue Following Q3 Merger - Stock Titan
2025-11-19-23.3%newsTradingViewProfusa, Inc. SEC 10-Q Report - TradingView
2026-04-13-21.9%newsBenzinga12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
2025-07-30-19.6%newsSeeking AlphaProfusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy
2025-07-30-19.6%newsInvesting.comProfusa stock falls after announcing $1 million Bitcoin investment By Investing.com - Investing.com
2026-02-27-19.5%newsGlobeNewswireProfusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
2026-02-27-19.5%earningsStock TitanBiotech Profusa scraps $15M stock sale after revenue outlook shifts - Stock Titan
2026-01-21+19.4%newsFinancialContentProfusa, Inc. - Common Stock (NQ: PFSA - FinancialContent
2026-04-08-19.1%newsXã Vĩnh CôngWhat upcoming catalysts matter for Profusa (PFSA) Stock | Price at $1.23, Down 1.60% - Price Surge - Xã Vĩnh Công
2026-02-19-19.1%earningsGlobeNewswireProfusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
2026-02-19-19.1%newsStock TitanSurgeons order Profusa oxygen monitors ahead of EU device sign-off - Stock Titan
2025-11-20-17.8%earningsSeeking AlphaProfusa, Inc. reports Q3 results
2025-12-31-17.5%M&AStock TitanNew French deal brings oxygen monitoring tech to critical limb patients - Stock Titan
2025-10-30-15.7%earningsSeeking AlphaProfusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026
2026-04-24-14.9%newsStock TitanProfusa (NASDAQ: PFSA) adds secured convertible note and 3.33M-share warrant - Stock Titan
2025-08-06-12.0%newsQuiver QuantitativeProfusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
2025-10-29-10.0%newsBenzingaWhy Profusa (PFSA) Stock Soared 36% After Hours? - Benzinga
2025-10-29-10.0%newsTechStock²Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound? - TechStock²
2026-04-20-9.6%newsCổng thông tin điện tử tỉnh Lào CaiProfusa (PFSA) Stock Dividend Growth (Underperforming) 2026-04-20 - Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
2026-03-26-7.9%earningsStock TitanProfusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
2026-04-29+7.0%newsStock TitanProfusa (NASDAQ: PFSA) revises convertible note as Nasdaq listing risk rises - Stock Titan
2025-10-07+6.9%newsSeeking AlphaProfusa invests additional $1 million in digital treasury assets
2025-09-07-6.1%newsFinimizeProfusa’s Risky Vision for High-Tech Medical Sensors - Finimize
2026-02-28-6.1%newsIntellectia AIPFSA Technical Analysis & Stock Price Forecast - Intellectia AI
2026-04-28+6.0%newsMT NewswiresTop Premarket Gainers
2026-04-27-3.5%M&AStock TitanProfusa (NASDAQ: PFSA) to acquire PanOmics assay assets in $30M stock deal - Stock Titan
2026-01-16-1.9%newsStock TitanDrug trials get new oxygen sensor as Profusa enters $47.9B CRO market - Stock Titan
2026-01-16-1.9%newsBenzingaProfusa Stock Spikes As Lumee System Targets Research Market - Benzinga
2026-01-22-1.4%newsIntellectia AIPFSA Forecast — Price Prediction for 2026. Should I Buy PFSA? - Intellectia AI
2026-02-02-0.7%newsStock TitanProfusa (PFSA) wins approval for reverse stock split range up to 1-for-200 - Stock Titan
2025-10-15+0.6%newsStock Titan~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe - Stock Titan
2026-04-30—newsStock TitanPFSA SEC Filings - Profusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
2025-07-11—newsStock TitanPFSA Stock Price, News & Analysis - Stock Titan
2025-07-11—newsStock TitanLatest PFSA News - Profusa Expands into Multi-Billion Dollar P... - Stock Titan
2025-07-11—newsGlobeNewswireProfusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq - GlobeNewswire
tickerdossier.comtickerdossier.substack.com